Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-15-086172

President & CEO bought 4,000 shares at $2.00 ($8,000)

From the SEC's structured data for this filing

Trades in this filing

USMAN NASSIM · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-12-17 Purchase : show line 1 in the form +4,000 $2.00 $8,000 78,375 I
Open-market purchases · 4,000 sh · avg $2.00 · $8,000
Loading xslF345X03/doc4.xml…